TRANSKARYOTIC THERAPIES, INC
Similar Organizations
HomeTech Therapies
HomeTech Therapies.
Profile Therapeutics
Profile Therapeutics
More informations about "Transkaryotic Therapies, Inc"
Transkaryotic Therapies, Inc - Crunchbase Company Profile
Organization. Transkaryotic Therapies, Inc . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Transkaryotic Therapies. ...See details»
Shire Pharmaceuticals Group plc To Build On Specialty ... - BioSpace
Transkaryotic Therapies, Inc. is a biopharmaceutical company primarily focused on researching, developing and commercializing treatments for rare diseases caused by protein deficiencies. …See details»
Transkaryotic Therapies - PitchBook
Transkaryotic Therapies General Information Description. Developer of bio-pharmaceutical products for treating rare diseases. The company develops gene-activated erythropoietin …See details»
TRANSKARYOTIC THERAPIES, INC - SEC.gov
TRANSKARYOTIC THERAPIES, INC. (Exact name of registrant as specified in its charter) Delaware: 04-3027191 (State or other jurisdiction of incorporation or organization) (I.R.S. …See details»
TRANSKARYOTIC THERAPIES Company Profile | Cambridge, MA
Find company research, competitor information, contact details & financial data for TRANSKARYOTIC THERAPIES of Cambridge, MA. Get the latest business insights from Dun …See details»
Transkaryotic Therapies, Inc. - Drug pipelines, Patents, Clinical ...
Explore Transkaryotic Therapies, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 10 news, and 1 literature, Drug:GA-II.See details»
TRANSKARYOTIC THERAPIES INC. - SEC.gov
Transkaryotic Therapies, Inc. (“TKT” or the “Company”) is a biopharmaceutical company researching, developing and commercializing therapeutics, primarily for the treatment of rare …See details»
Transkaryotic Therapies, Inc. - BioPharmaLink
May 14, 2001 Transkaryotic Therapies, Inc.: Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company dedicated to the development and commercialization of products …See details»
Transkaryotic Therapies, Inc. - SEC.gov
Transkaryotic Therapies, Inc. We are a biopharmaceutical company researching, developing and commercializing therapeutics, primarily for the treatment of rare genetic diseases caused by …See details»
Transkaryotic Therapies, Inc - Cambridge , MA - Business Profile
Transkaryotic Therapies, Inc CLAIM THIS BUSINESS. 700 MAIN ST CAMBRIDGE, MA 02139 Get Directions (617) 349-0200. Business Info. Founded 2005; Incorporated DE; Annual …See details»
Transkaryotic Therapies, Inc. Confirms That Board of Directors ...
Transkaryotic Therapies, Inc. is a biopharmaceutical company primarily focused on researching, developing and commercializing treatments for rare diseases caused by protein deficiencies. …See details»
TRANSKARYOTIC THERAPIES INC - 10-K Annual Report - 12/31/2000
TRANSKARYOTIC THERAPIES, INC. (Exact name of registrant as specified in its charter)----- ... (I.R.S. Employer incorporation or organization) Identification No.) 195 Albany Street …See details»
Transkaryotic Therapies - Products, Competitors, Financials, …
Transkaryotic Therapies (NASDAQ: TKTX) develops technologies for the production of human proteins and for gene therapy systems. Products developed with these technologies include …See details»
In re Transkaryotic Therapies, Inc. :: 2008 - Justia Law
Transkaryotic Therapies, Inc. and Shire plc at 36 n.40; Reply Br. of Defs. Transkaryotic Therapies, Inc. and Shire plc at 8. The inspector of election determined that 35,624,361 shares of …See details»
Delaware Chancery Clarifies Appraisal Rights - 1 - The Harvard Law ...
May 14, 2007 On April 21, 2005, Transkaryotic Therapies, Inc. (“TKT”), a biopharmaceutical company, announced that it had signed a definitive agreement with Shire Pharmaceuticals …See details»
Transkaryotic Therapies, Inc. - SEC.gov
Transkaryotic Therapies, Inc. is a biopharmaceutical company primarily focused on researching, developing and commercializing treatments for rare diseases caused by protein deficiencies. …See details»
Transkaryotic Therapies Gains Patent for Gene Activation Technology
The U.S. Patent and Trademark Office issued Transkaryotic Therapies Inc. (Cambridge, MA) a patent relating to the company's proprietary gene activation technology and approach to gene …See details»
TRANSKARYOTIC THERAPIES INC - HIPAASpace
TRANSKARYOTIC THERAPIES INC BUSINESS ADDRESS EIN 043027191 An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used …See details»
Patent Baristas » Amgen V: Does It Matter How Therapeutically …
Nov 28, 2006 Earlier, the Court of Appeals for the Federal Circuit affirmed a District Court’s decision that Transkaryotic Therapies Inc. (TKT) and Aventis Pharmaceuticals Inc. infringe …See details»
Amgen IV: The Return of the Therapeutically Effective Amount
Aug 16, 2006 In Amgen Inc., v.Hoechst Marion Roussel, Inc. (Now Aventis) and Transkaryotic Therapies, Inc., (05-1157), the Court of Appeals for the Federal Circuit affirmed a District …See details»